668 related articles for article (PubMed ID: 26756576)
1. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
[TBL] [Abstract][Full Text] [Related]
2. Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control study.
Zhang Y; Dou Z
Stem Cell Res Ther; 2014 May; 5(3):66. PubMed ID: 24887638
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
[TBL] [Abstract][Full Text] [Related]
4. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.
Gabr MM; Zakaria MM; Refaie AF; Ismail AM; Abou-El-Mahasen MA; Ashamallah SA; Khater SM; El-Halawani SM; Ibrahim RY; Uin GS; Kloc M; Calne RY; Ghoneim MA
Cell Transplant; 2013; 22(1):133-45. PubMed ID: 22710060
[TBL] [Abstract][Full Text] [Related]
5. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro.
Xie QP; Huang H; Xu B; Dong X; Gao SL; Zhang B; Wu YL
Differentiation; 2009 Jun; 77(5):483-91. PubMed ID: 19505629
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro.
Sun Y; Chen L; Hou XG; Hou WK; Dong JJ; Sun L; Tang KX; Wang B; Song J; Li H; Wang KX
Chin Med J (Engl); 2007 May; 120(9):771-6. PubMed ID: 17531117
[TBL] [Abstract][Full Text] [Related]
7. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells.
Li Y; Zhang R; Qiao H; Zhang H; Wang Y; Yuan H; Liu Q; Liu D; Chen L; Pei X
J Cell Physiol; 2007 Apr; 211(1):36-44. PubMed ID: 17226789
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.
Gabr MM; Zakaria MM; Refaie AF; Khater SM; Ashamallah SA; Ismail AM; El-Halawani SM; Ghoneim MA
Biomed Res Int; 2015; 2015():575837. PubMed ID: 26064925
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic islet-like clusters from bone marrow mesenchymal stem cells of human first-trimester abortus can cure streptozocin-induced mouse diabetes.
Zhang Y; Shen W; Hua J; Lei A; Lv C; Wang H; Yang C; Gao Z; Dou Z
Rejuvenation Res; 2010 Dec; 13(6):695-706. PubMed ID: 21204652
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
[TBL] [Abstract][Full Text] [Related]
11. A secretory function of human insulin-producing cells in vivo.
Hu YH; Wu DQ; Gao F; Li GD; Yao L; Zhang XC
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):255-60. PubMed ID: 19502164
[TBL] [Abstract][Full Text] [Related]
12. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
Sharma A; Rani R
Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
[TBL] [Abstract][Full Text] [Related]
13. The Differences in the Characteristics of Insulin-producing Cells Using Human Adipose-tissue Derived Mesenchymal Stem Cells from Subcutaneous and Visceral Tissues.
Wada Y; Ikemoto T; Morine Y; Imura S; Saito Y; Yamada S; Shimada M
Sci Rep; 2019 Sep; 9(1):13204. PubMed ID: 31519950
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats.
Neshati Z; Matin MM; Bahrami AR; Moghimi A
J Physiol Biochem; 2010 Jun; 66(2):181-7. PubMed ID: 20422338
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cell differentiation into insulin secreting β-cells for diabetes.
Bose B; Shenoy SP; Konda S; Wangikar P
Cell Biol Int; 2012 Nov; 36(11):1013-20. PubMed ID: 22897387
[TBL] [Abstract][Full Text] [Related]
16. Human insulin secreted from insulinogenic xenograft restores normoglycemia in type 1 diabetic mice without immunosuppression.
Kim J; Park S; Kang HM; Ahn CW; Kwon HC; Song JH; Lee YJ; Lee KH; Yang H; Baek SY; Yoo SH; Kim SH; Kim H
Cell Transplant; 2012; 21(10):2131-47. PubMed ID: 22490341
[TBL] [Abstract][Full Text] [Related]
17. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
Amer MG; Embaby AS; Karam RA; Amer MG
Gene; 2018 May; 654():87-94. PubMed ID: 29452233
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of human adipose-derived mesenchymal stem cell into insulin-producing cells: an in vitro study.
Moshtagh PR; Emami SH; Sharifi AM
J Physiol Biochem; 2013 Sep; 69(3):451-8. PubMed ID: 23271274
[TBL] [Abstract][Full Text] [Related]
19. Insulin-producing cells derived from rat bone marrow and their autologous transplantation in the duodenal wall for treating diabetes.
Zhang YH; Wang HF; Liu W; Wei B; Bing LJ; Gao YM
Anat Rec (Hoboken); 2009 May; 292(5):728-35. PubMed ID: 19382247
[TBL] [Abstract][Full Text] [Related]
20. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells.
Wu XH; Liu CP; Xu KF; Mao XD; Zhu J; Jiang JJ; Cui D; Zhang M; Xu Y; Liu C
World J Gastroenterol; 2007 Jun; 13(24):3342-9. PubMed ID: 17659673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
